| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 35 |
| 1 | MYCOPHENOLATE MOFETIL | 26 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 26 |
| 3 | TACROLIMUS | 25 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 |
| 5 | TACROLIMUS OINTMENT 0.1% | 25 |
| 6 | SIROLIMUS | 24 |
| 7 | PEMBROLIZUMAB | 19 |
| 8 | CARBOPLATIN | 16 |
| 9 | CISPLATIN | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STREPTOZOCIN | 2 | 0.0087 |
| 1 | NIROGACESTAT | 3 | 0.0033 |
| 2 | SIROLIMUS | 24 | 0.0018 |
| 3 | MOGAMULIZUMAB-KPKC | 2 | 0.0015 |
| 4 | GANCICLOVIR SODIUM | 14 | 0.0013 |
| 5 | SULINDAC | 3 | 0.0012 |
| 6 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 7 | IXABEPILONE | 1 | 0.0010 |
| 8 | LEMBOREXANT | 2 | 0.0007 |
| 9 | VALGANCICLOVIR | 12 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gamma Secretase Inhibitor [EPC] | 3 | 0.0033 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 2 | 0.0015 |
| 2 | Monobactam Antibacterial [EPC] | 3 | 0.0011 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 15 | 0.0007 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 45 | 0.0005 |
| 6 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 8 | 0.0004 |
| 8 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Nucleoside Analog Antiviral [EPC] | 15 | 0.0002 |